Segments (Tables)

3 Months Ended

Mar. 31, 2021

Segment Reporting [Abstract]

Schedule of Segment Information

The following table summarizes the Company’s segment information for the following balance sheet dates presented, and for the three months ended March 31, 2021 and 2020:

	Property Development			Digital Transformation Technology			Biohealth Business			Other			Total
Three Months Ended March 31, 2021
Revenue	$	3,894,131		$	-		$	1,712,783		$	-		$	5,606,914
Cost of Sales		(3,614,832	)		-			(83,022	)		-			(3,697,854	)
Gross Margin		279,299			-			1,629,761			-			1,909,060
Operating Expenses		(359,489	)		(30,128	)		(846,480	)		(1,076,408	)		(2,312,505	)
Operating Income (Loss)		(80,190	)		(30,128	)		783,281			(1,076,408	)		(403,445	)
Other Income (Expense)		(9,873	)		(36,471	)		(8,371,117	)		(532,505	)		(8,949,966	)
Net Income (Loss) Before Income Tax		(90,063	)		(66,599	)		(7,587,836	)		(1,608,913	)		(9,353,411	)

	Property Development			Digital Transformation Technology			Biohealth Business			Other			Total
Three Months ended March 31, 2020
Revenue	$	2,954,389		$	-		$	10,782		$	-		$	2,965,171
Cost of Sales		(2,380,820	)		-			(2,883	)		-			(2,383,703	)
Gross Margin		573,569			-			7,899			-			581,468
Operating Expenses		(277,056	)		(18,228	)		(132,791	)		(575,784	)		(1,003,859	)
Operating Income (Loss)		296,513			(18,228	)		(124,892	)		(575,784	)		(422,391	)
Other Income (Expense)		7,539			(92,477	)		193			2,762,701			2,677,956
Net Income (Loss) Before Income Tax		304,052			(110,705	)		(124,699	)		2,186,917			2,255,565
March 31, 2021
Cash and Restricted Cash	$	9,842,218		$	154,738		$	3,251,622		$	15,756,505		$	29,005,083
Total Assets		30,877,470			154,840			43,241,793			34,523,886			108,797,989
December 31, 2020
Cash and Restricted Cash	$	8,150,769		$	158,058		$	1,590,265		$	21,336,364		$	31,235,456
Total Assets		28,954,484			158,160			524,603			77,574,674			107,211,921